Management of Adenovirus in Children after Allogeneic Hematopoietic Stem Cell Transplantation

Advances in Hematology

Volumn 2013, Issue , 2013, Pages

  Wy Ip, Winnie ^a   Qasim, Waseem ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; ANTIVIRUS AGENT; CIDOFOVIR; CIDOFOVIR 3 HEXADECYLOXYPROPYL ESTER; CYCLOSPORIN; DOUBLE STRANDED DNA; PROBENECID; RIBAVIRIN; TACROLIMUS; VIRUS DNA;

ADENOVIRUS; ADOPTIVE IMMUNOTHERAPY; ADOPTIVE TRANSFER; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIGEN SPECIFICITY; BRONCHIOLITIS; CELL ISOLATION; CELLULAR IMMUNITY; CHILDHOOD MORTALITY; CREATININE BLOOD LEVEL; CYTOKINE RELEASE; CYTOMEGALOVIRUS INFECTION; CYTOTOXIC T LYMPHOCYTE; DISEASE SEVERITY; GENOME; GRAFT VERSUS HOST REACTION; HEMAGGLUTINATION; HLA SYSTEM; HUMAN; HUMAN ADENOVIRUS INFECTION; HUMORAL IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; INCIDENCE; INFECTION RISK; LYMPHOCYTE COUNT; LYMPHOCYTOPENIA; MAST CELL; MORBIDITY; NEPHROTOXICITY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEINURIA; REVIEW; RISK FACTOR; SEROTYPE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRAL CLEARANCE; VIRAL GENE DELIVERY SYSTEM; VIREMIA; VIRUS ISOLATION; VIRUS LOAD; VIRUS PNEUMONIA;

EID: 84888591443     PISSN: 16879104     EISSN: 16879112     Source Type: Journal    
DOI: 10.1155/2013/176418     Document Type: Review

References (76)

1. Rowe W. P., Huebner R. J., Gilmore L. K., Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture. Proceedings of the Society for Experimental Biology and Medicine 1953 84 3 570 573
2. Walls T., Shankar A. G., Shingadia D., Adenovirus: an increasingly important pathogen in paediatric bone marrow transplant patients. The Lancet Infectious Diseases 2003 3 2 79 86 2-s2.0-0037310655 10.1016/S1473-3099(03) 00515-2 (Pubitemid 36164203)
3. Heim A., Advances in the management of disseminated adenovirus disease in stem cell transplant recipients: impact of adenovirus load (DNAemia) testing. Expert Review of Anti-Infective Therapy 2011 9 11 943 945 2-s2.0-80155197746 10.1586/eri.11.113
4. Lion T., Baumgartinger R., Watzinger F., Matthes-Martin S., Suda M., Preuner S., Futterknecht B., Lawitschka A., Peters C., Pötschger U., Gadner H., Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. Blood 2003 102 3 1114 1120 2-s2.0-0043245804 10.1182/blood-2002-07-2152 (Pubitemid 36917814)
5. Kojaoghlanian T., Flomenberg P., Horwitz M. S., The impact of adenovirus infection on the immunocompromised host. Reviews in Medical Virology 2003 13 3 155 171 2-s2.0-0038029587 10.1002/rmv.386 (Pubitemid 36566085)
6. Robinson C. M., Singh G., Lee J. Y., Molecular evolution of human adenoviruses. Scientific Reports 2013 3 1812
7. Hierholzer J. C., Adenoviruses in the immunocompromised host. Clinical Microbiology Reviews 1992 5 3 262 274 2-s2.0-0026771406
8. Lenaerts L., De Clercq E., Naesens L., Clinical features and treatment of adenovirus infections. Reviews in Medical Virology 2008 18 6 357 374 2-s2.0-57049146779 10.1002/rmv.589
9. Toogood C. I. A., Crompton J., Hay R. T., Antipeptide antisera define neutralizing epitopes on the adenovirus hexon. Journal of General Virology 1992 73 6 1429 1435 2-s2.0-0026654483
10. Gahéry-Ségard H., Farace F., Godfrin D., Gaston J., Lengagne R., Tursz T., Boulanger P., Guillet J.-G., Immune response to recombinant capsid proteins of adenovirus in humans: antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity. Journal of Virology 1998 72 3 2388 2397 2-s2.0-2642702620 (Pubitemid 28100799)
11. Sumida S. M., Truitt D. M., Lemckert A. A. C., Vogels R., Custers J. H. H. V., Addo M. M., Lockman S., Peter T., Peyerl F. W., Kishko M. G., Jackson S. S., Gorgone D. A., Lifton M. A., Essex M., Walker B. D., Goudsmit J., Havenga M. J. E., Barouch D. H., Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein. Journal of Immunology 2005 174 11 7179 7185 2-s2.0-21044439669 (Pubitemid 40705685)
12. + T lymphocytes both contribute to immunity to adenovirus serotype 5 vaccine vectors. Journal of Virology 2004 78 6 2666 2673 2-s2.0-12144291467 10.1128/JVI.78.6.2666-2673.2004 (Pubitemid 38314325)
13. Heemskerk B., Lankester A. C., Van Vreeswijk T., Beersma M. F. C., Claas E. C. J., Veltrop-Duits L. A., Kroes A. C. M., Vossen J. M. J. J., Schilham M. W., Van Tol M. J. D., Immune reconstitution and clearance of human adenovirus viremia in pediatric stem-cell recipients. Journal of Infectious Diseases 2005 191 4 520 530 2-s2.0-13444256480 10.1086/427513 (Pubitemid 40216667)
14. Legrand F., Berrebi D., Houhou N., Freymuth F., Faye A., Duval M., Mougenot J. F., Peuchmaur M., Vilmer E., Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children. Bone Marrow Transplantation 2001 27 6 621 626 2-s2.0-0035038269 10.1038/sj.bmt.1702820 (Pubitemid 32401460)
15. Ljungman P., Treatment of adenovirus infections in the immunocompromised host. European Journal of Clinical Microbiology and Infectious Diseases 2004 23 8 583 588 2-s2.0-4544261298 10.1007/s10096-004-1165-x (Pubitemid 39222630)
16. Flomenberg P., Piaskowski V., Truitt R. L., Casper J. T., Characterization of human proliferative T cell responses to adenovirus. Journal of Infectious Diseases 1995 171 5 1090 1096 2-s2.0-0028897676
17. Smith C. A., Woodruff L. S., Kitchingman G. R., Rooney C. M., Adenovirus-pulsed dendritic cells stimulate human virus-specific T-cell responses in vitro. Journal of Virology 1996 70 10 6733 6740 2-s2.0-0029793811 (Pubitemid 26307380)
18. Smith C. A., Woodruff L. S., Rooney C., Kitchingman G. R., Extensive cross-reactivity of adenovirus-specific cytotoxic T cells. Human Gene Therapy 1998 9 10 1419 1427 2-s2.0-0032127610 (Pubitemid 28379081)
19. + adenovirus-specific T cells: implications for immunotherapy and gene therapy. Journal of Virology 2003 77 11 6562 6566 2-s2.0-0037688132 10.1128/JVI.77.11.6562-6566.2003 (Pubitemid 36588428)
20. + T-cell epitope. Human Gene Therapy 2002 13 10 1167 1178 2-s2.0-0036019189 10.1089/104303402320138952 (Pubitemid 34746697)
21. + T cells. Blood 2004 104 8 2432 2440 2-s2.0-4944223121 10.1182/blood-2004-02-0646 (Pubitemid 39331844)
22. + cytotoxic T cell responses to adenovirus capsid proteins. Virology 2006 350 2 312 322 2-s2.0-33745264376 10.1016/j.virol.2006.01.024 (Pubitemid 43928100)
23. Tang J., Olive M., Champagne K., Flomenberg N., Eisenlohr L., Hsu S., Flomenberg P., Adenovirus hexon T-cell epitope is recognized by most adults and is restricted by HLA DP4, the most common class II allele. Gene Therapy 2004 11 18 1408 1415 2-s2.0-4644237559 10.1038/sj.gt.3302316 (Pubitemid 39263894)
24. Leen A. M., Christin A., Khalil M., Weiss H., Gee A. P., Brenner M. K., Heslop H. E., Rooney C. M., Bollard C. M., Identification of hexon-specific CD4 and CD8 T-cell epitopes for vaccine and immunotherapy. Journal of Virology 2008 82 1 546 554 2-s2.0-37349101246 10.1128/JVI.01689-07 (Pubitemid 350309169)
25. + adenovirus hexon-specific T cells associated with viral clearance after stem cell transplantation as treatment for adenovirus infection. Haematologica 2010 95 11 1943 1951 2-s2.0-78149249171 10.3324/haematol.2010.022947
26. Hale G. A., Heslop H. E., Krance R. A., Brenner M. A., Jayawardene D., Srivastava D. K., Patrick C. C., Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transplantation 1999 23 3 277 282 2-s2.0-0032992434 (Pubitemid 29078342)
27. Carrigan D. R., Adenovirus infections in immunocompromised patients. American Journal of Medicine 1997 102 3A 71 74 2-s2.0-0031000237
28. Shields A. F., Hackman R. C., Fife K. H., Adenovirus infections in patients undergoing bone marrow transplantation. The New England Journal of Medicine 1985 312 9 529 533 2-s2.0-0021930668 (Pubitemid 15174147)
29. Flomenberg P., Babbitt J., Drobyski W. R., Ash R. C., Carrigan D. R., Sedmak G. V., McAuliffe T., Camitta B., Horowitz M. M., Bunin N., Casper J. T., Increasing incidence of adenovirus disease in bone marrow transplant recipients. Journal of Infectious Diseases 1994 169 4 775 781 2-s2.0-0028256278 (Pubitemid 24102109)
30. Howard D. S., Phillips G. L. II, Reece D. E., Munn R. K., Henslee-Downey J., Pittard M., Barker M., Pomeroy C., Adenovirus infections in hematopoietic stem cell transplant recipients. Clinical Infectious Diseases 1999 29 6 1494 1501 2-s2.0-0033396237 10.1086/313514 (Pubitemid 30022747)
31. Baldwin A., Kingman H., Darville M., Foot A. B. M., Grier D., Cornish J. M., Goulden N., Oakhill A., Pamphilon D. H., Steward C. G., Marks D. I., Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation. Bone Marrow Transplantation 2000 26 12 1333 1338 2-s2.0-17744362865 10.1038/sj.bmt.1702716 (Pubitemid 32098053)
32. Runde V., Ross S., Trenschel R., Lagemann E., Basu O., Renzing-Köhler K., Schaefer U. W., Roggendorf M., Holler E., Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study. Bone Marrow Transplantation 2001 28 1 51 57 2-s2.0-0034899711 10.1038/sj.bmt.1703083 (Pubitemid 32707617)
33. Kampmann B., Cubitt D., Walls T., Naik P., Depala M., Samarasinghe S., Robson D., Hassan A., Rao K., Gaspar H., Davies G., Jones A., Cale C., Gilmour K., Real M., Foo M., Bennett-Rees N., Hewitt A., Amrolia P., Veys P., Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation. British Journal of Haematology 2005 130 4 595 603 2-s2.0-24944570191 10.1111/j.1365-2141.2005.05649.x (Pubitemid 43899764)
34. Chakrabarti S., Mautner V., Osman H., Collingham K. E., Fegan C. D., Klapper P. E., Moss P. A. H., Milligan D. W., Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. Blood 2002 100 5 1619 1627 2-s2.0-0036720393 10.1182/blood-2002-02-0377 (Pubitemid 34925137)
35. Feuchtinger T., Lücke J., Hamprecht K., Richard C., Handgretinger R., Schumm M., Greil J., Bock T., Niethammer D., Lang P., Detection of adenovirus-specific T cells in children with adenovirus infection after allogeneic stem cell transplantation. British Journal of Haematology 2005 128 4 503 509 2-s2.0-20044380342 10.1111/j.1365-2141.2004.05331.x (Pubitemid 40283168)
36. Hiwarkar P., Gaspar H. B., Gilmour K., Impact of viral reactivations in the era of pre-emptive antiviral drug therapy following allogeneic haematopoietic SCT in paediatric recipients. Bone Marrow Transplant 2013 48 6 803 808 10.1038/bmt.2012.221
37. Munoz F. M., Piedra P. A., Demmler G. J., Disseminated adenovirus disease in immunocompromised and immunocompetent children. Clinical Infectious Diseases 1998 27 5 1194 1200 2-s2.0-0032458786 (Pubitemid 29242469)
38. Feuchtinger T., Richard C., Pfeiffer M., Neuhäuser F., Lücke J., Handgretinger R., Greil J., Bader P., Klingebiel T., Schlegel P. G., Jahn G., Niethammer D., Lang P., Adenoviral infections after transplantation of positive selected stem cells from haploidentical donors in children: an update. Klinische Padiatrie 2005 217 6 339 344 2-s2.0-28544440253 10.1055/s-2005-872530 (Pubitemid 41746116)
39. Erard V., Huang M.-L., Ferrenberg J., Nguy L., Stevens-Ayers T. L., Hackman R. C., Corey L., Boeckh M., Quantitative real-time polymerase chain reaction for detection of adenovirus after T cell-replete hematopoietic cell transplantation: viral load as a marker for invasive disease. Clinical Infectious Diseases 2007 45 8 958 965 2-s2.0-34848825923 10.1086/521851 (Pubitemid 47580342)
40. Schilham M. W., Claas E. C., Van Zaane W., Heemskerk B., Vossen J. M., Lankester A. C., Toes R. E., Echavarria M., Kroes A. C., Van Tol M. J., High levels of adenovirus DNA in serum correlate with fatal outcome of adenovirus infection in children after allogeneic stem-cell transplantation. Clinical Infectious Diseases 2002 35 5 526 532 2-s2.0-0036721210 10.1086/341770
41. Sellar R. S., Peggs K. S., Management of multidrug-resistant viruses in the immunocompromised host. British Journal of Haematology 2012 156 5 559 572 2-s2.0-84857034596 10.1111/j.1365-2141.2011.08988.x
42. Hoffman J. A., Shah A. J., Ross L. A., Kapoor N., Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation 2001 7 7 388 394 2-s2.0-0034858413 (Pubitemid 32799057)
43. Bordigoni P., Carret A.-S., Venard V., Witz F., Faou A. L., Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation. Clinical Infectious Diseases 2001 32 9 1290 1297 2-s2.0-0035341289 10.1086/319984 (Pubitemid 32405900)
44. Ljungman P., Ribaud P., Eyrich M., Matthes-Martin S., Einsele H., Bleakley M., Machaczka M., Bierings M., Bosi A., Gratecos N., Cordonnier C., Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplantation 2003 31 6 481 486 2-s2.0-0037366835 10.1038/sj.bmt.1703798 (Pubitemid 36511815)
45. Yusuf U., Hale G. A., Carr J., Gu Z., Benaim E., Woodard P., Kasow K. A., Horwitz E. M., Leung W., Srivastava D. K., Handgretinger R., Hayden R. T., Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients. Transplantation 2006 81 10 1398 1404 2-s2.0-33744924744 10.1097/01.tp.0000209195.95115.8e (Pubitemid 43847149)
46. Neofytos D., Ojha A., Mookerjee B., Wagner J., Filicko J., Ferber A., Dessain S., Grosso D., Brunner J., Flomenberg N., Flomenberg P., Treatment of adenovirus disease in stem cell transplant recipients with cidofovir. Biology of Blood and Marrow Transplantation 2007 13 1 74 81 2-s2.0-33846015837 10.1016/j.bbmt.2006.08.040 (Pubitemid 46044089)
47. Lindemans C. A., Leen A. M., Boelens J. J., How I treat adenovirus in hematopoietic stem cell transplant recipients. Blood 2010 116 25 5476 5485 2-s2.0-78650489175 10.1182/blood-2010-04-259291
48. Lacy S. A., Hitchcock M. J. M., Lee W. A., Tellier P., Cundy K. C., Effect of oral probenecid coadministration on the chronic toxicity and pharmacokinetics of intravenous cidofovir in cynomolgus monkeys. Toxicological Sciences 1998 44 2 97 106 2-s2.0-0031716603 10.1006/toxs.1998.2481 (Pubitemid 28415221)
49. Morfin F., Dupuis-Girod S., Frobert E., Mundweiler S., Carrington D., Sedlacek P., Bierings M., Cetkovsky P., Kroes A. C. M., van Tol M. J. D., Thouvenot D., Differential susceptibility of adenovirus clinical isolates to cidofovir and ribavirin is not related to species alone. Antiviral Therapy 2009 14 1 55 61 2-s2.0-61849139529
50. Lankester A. C., Heemskerk B., Claas E. C. J., Schilham M. W., Beersma M. F. C., Bredius R. G. M., Van Tol M. J. D., Kroes A. C. M., Effect of ribavirin on the plasma viral DNA load in patients with disseminating adenovirus infection. Clinical Infectious Diseases 2004 38 11 1521 1525 2-s2.0-2942620299 10.1086/420817 (Pubitemid 38738544)
51. Florescu D. F., Pergam S. A., Neely M. N., Qiu F., Johnston C., Way S., Sande J., Lewinsohn D. A., Guzman-Cottrill J. A., Graham M. L., Papanicolaou G., Kurtzberg J., Rigdon J., Painter W., Mommeja-Marin H., Lanier R., Anderson M., van der Horst C., Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients. Biology of Blood and Marrow Transplantation 2012 18 5 731 738 2-s2.0-84859872029 10.1016/j.bbmt.2011.09.007
52. Papadopoulos E. B., Ladanyi M., Emanuel D., Mackinnon S., Boulad F., Carabasi M. H., Castro-Malaspina H., Childs B. H., Gillio A. P., Small T. N., Young J. W., Kernan N. A., OReilly R. J., Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. The New England Journal of Medicine 1994 330 17 1185 1191 2-s2.0-0028288519 10.1056/NEJM199404283301703 (Pubitemid 24121987)
53. Walter E. A., Greenberg P. D., Gilbert M. J., Finch R. J., Watanabe K. S., Thomas E. D., Riddell S. R., Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. The New England Journal of Medicine 1995 333 16 1038 1044 2-s2.0-0028820386 10.1056/NEJM199510193331603
54. Hromas R., Cornetta K., Srour E., Blanke C., Broun E. R., Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation. Blood 1994 84 5 1689 1690 2-s2.0-0027998850 (Pubitemid 24273046)
55. Bollard C. M., Kuehnle I., Leen A., Rooney C. M., Heslop H. E., Adoptive immunotherapy for posttransplantation viral infections. Biology of Blood and Marrow Transplantation 2004 10 3 143 155 2-s2.0-1342330261 10.1016/j.bbmt.2003. 09.017 (Pubitemid 38262877)
56. Leen A. M., Rooney C. M., Adenovirus as an emerging pathogen in immunocompromised patients. British Journal of Haematology 2005 128 2 135 144 2-s2.0-12744253470 10.1111/j.1365-2141.2004.05218.x
57. Leen A. M., Myers G. D., Bollard C. M., Huls M. H., Sili U., Gee A. P., Heslop H. E., Rooney C. M., T-cell immunotherapy for adenoviral infections of stem-cell transplant recipients. Annals of the New York Academy of Sciences 2005 1062 104 115 2-s2.0-33745486779 10.1196/annals.1358.013
58. Leen A. M., Tripic T., Rooney C. M., Challenges of T cell therapies for virus-associated diseases after hematopoietic stem cell transplantation. Expert Opinion on Biological Therapy 2010 10 3 337 351 2-s2.0-76949107081 10.1517/14712590903456003
59. Leen A. M., Sili U., Savoldo B., Jewell A. M., Piedra P. A., Brenner M. K., Rooney C. M., Fiber-modified adenoviruses generate subgroup cross-reactive, adenovirus-specific cytotoxic T lymphocytes for therapeutic applications. Blood 2004 103 3 1011 1019 2-s2.0-1342323794 10.1182/blood-2003-07-2449 (Pubitemid 38129564)
60. Qasim W., Gilmour K., Zhan H., Interferon-gamma capture T cell therapy for persistent Adenoviraemia following allogeneic haematopoietic stem cell transplantation. British Journal of Haematology 2013 161 3 449 452
61. Aïssi-Rothe L., Decot V., Venard V., Jeulin H., Salmon A., Clement L., Kennel A., Mathieu C., Dalle J. H., Rauser G., Cambouris C., De Carvalho M., Stoltz J. F., Bordigoni P., Bensoussan D., Rapid generation of full clinical-grade human antiadenovirus cytotoxic t cells for adoptive immunotherapy. Journal of Immunotherapy 2010 33 4 414 424 2-s2.0-77954894222 10.1097/CJI.0b013e3181cc263b
62. Leen A. M., Myers G. D., Sili U., Huls M. H., Weiss H., Leung K. S., Carrum G., Krance R. A., Chang C.-C., Molldrem J. J., Gee A. P., Brenner M. K., Heslop H. E., Rooney C. M., Bollard C. M., Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals. Nature Medicine 2006 12 10 1160 1166 2-s2.0-33749514632 10.1038/nm1475 (Pubitemid 44527351)
63. Fujita Y., Rooney C. M., Heslop H. E., Adoptive cellular immunotherapy for viral diseases. Bone Marrow Transplantation 2008 41 2 193 198 2-s2.0-38849159100 10.1038/sj.bmt.1705906 (Pubitemid 351188917)
64. Leen A. M., Christin A., Myers G. D., Liu H., Cruz C. R., Hanley P. J., Kennedy-Nasser A. A., Leung K. S., Gee A. P., Krance R. A., Brenner M. K., Heslop H. E., Rooney C. M., Bollard C. M., Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation. Blood 2009 114 19 4283 4292 2-s2.0-74949113395 10.1182/blood-2009-07-232454
65. Leen A. M., Bollard C. M., Mendizabal A. M., Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation. Blood 2013 121 26 5113 5123
66. + T cells according to IFN- γ secretion for adjuvant immunotherapy. Experimental Hematology 2004 32 3 282 289 2-s2.0-1542267415 10.1016/j.exphem.2003.12.009 (Pubitemid 38328534)
67. Feuchtinger T., Matthes-Martin S., Richard C., Lion T., Fuhrer M., Hamprecht K., Handgretinger R., Peters C., Schuster F. R., Beck R., Schumm M., Lotfi R., Jahn G., Lang P., Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation. British Journal of Haematology 2006 134 1 64 76 2-s2.0-33744788680 10.1111/j.1365-2141.2006.06108.x (Pubitemid 43830030)
68. Gerdemann U., Katari U. L., Papadopoulou A., Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for Adenovirus, EBV and CMV infections after allogeneic hematopoietic stem cell transplant. Molecular Therapy 2013 10.1038/mt.2013.151
69. Chatziandreou I., Gilmour K. C., McNicol A.-M., Costabile M., Sinclair J., Cubitt D., Campbell J. D. M., Kinnon C., Qasim W., Bobby Gaspar H., Capture and generation of adenovirus specific T cells for adoptive immunotherapy. British Journal of Haematology 2007 136 1 117 126 2-s2.0-33845491467 10.1111/j.1365-2141.2006.06386.x (Pubitemid 44912597)
70. Qasim W., Derniame S., Gilmour K., Chiesa R., Weber M., Adams S., Rao K., Amrolia P., Goulden N., Veys P., Gaspar H., Third-party virus-specific T cells eradicate adenoviraemia but trigger bystander graft-versus-host disease. British Journal of Haematology 2011 154 1 150 153 2-s2.0-79958847949 10.1111/j.1365-2141.2011.08579.x
71. Comoli P., Schilham M. W., Basso S., Van Vreeswijk T., Bernardo M. E., Maccario R., Van Tol M. J. D., Locatelli F., Veltrop-Duits L. A., T-cell lines specific for peptides of adenovirus hexon protein and devoid of alloreactivity against recipient cells can be obtained from HLA-haploidentical donors. Journal of Immunotherapy 2008 31 6 529 536 2-s2.0-48549101673 10.1097/CJI. 0b013e31817b9c6b
72. Gerdemann U., Vera J. F., Rooney C. M., Leen A. M., Generation of multivirus-specific T cells to prevent/treat viral infections after allogeneic hematopoietic stem cell transplant. Journal of Visualized Experiments 2011 51
73. Gerdemann U., Keirnan J. M., Katari U. L., Rapidly generated multivirus-specific cytotoxic T lymphocytes for the prophylaxis and treatment of viral infections. Molecular Therapy 2012 20 8 1622 1632
74. Khanna N., Stuehler C., Conrad B., Lurati S., Krappmann S., Einsele H., Berges C., Topp M. S., Generation of a multipathogen-specific T-cell product for adoptive immunotherapy based on activation-dependent expression of CD154. Blood 2011 118 4 1121 1131 2-s2.0-79960976245 10.1182/blood-2010-12-322610
75. Leibold J., Feucht J., Halder A., Induction of Thelper1-driven antiviral T-cell lines for adoptive immunotherapy is determined by differential expression of IFN-gamma and T-cell activation markers. Journal of Immunotherapy 2012 35 9 661 669
76. + adenovirus-specific T-cells with artificial antigen presenting cells. Clinical Immunology 2013 146 3 228 239